Polymerase chain reaction (PCR) has revolutionized the field of molecular diagnostics since its conception in 1983. Roche has played a pioneering role from the start.
This innovative, Nobel-prize winning, technology allows clinicians to diagnose infectious disease, detect genetic variations and mutations, or track down the source of a viral infection – all from the DNA or RNA contained in a single cell or patient sample such as blood, skin cells, saliva or hair.
Polymerase chain reaction (PCR) is an efficient and cost-effective way to copy or “amplify” small segments of DNA or RNA.
Today, polymerase chain reaction (PCR) makes its presence felt in a wide array of applications, from forensic science and matching organ donors to identifying endangered species.